Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, no par value
-
Shares outstanding
-
109,272,143
-
Total 13F shares
-
384,390
-
Share change
-
-6,225
-
Total reported value
-
$1,816,270
-
Price per share
-
$4.75
-
Number of holders
-
23
-
Value change
-
+$231,441
-
Number of buys
-
15
-
Number of sells
-
6
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q4 2019
As of 31 Dec 2019,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
384,390 shares.
The largest 10 holders included
MORGAN STANLEY, ROYAL BANK OF CANADA, SCOTIA CAPITAL INC., CITADEL ADVISORS LLC, CIBC World Markets Inc., Federation des caisses Desjardins du Quebec, JANE STREET GROUP, LLC, Crescent Grove Advisors, LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., and BANK OF MONTREAL /CAN/.
This page lists
23
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.